Surgery Partners, Inc.

Surgery Partners, Inc.

SGRYยทNASDAQ

$13.51

+2.2%
HealthcareMedical - Care Facilities

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

At a Glance

Live Snapshot
Market Cap$1.77B
EPS-0.6100
P/E Ratio-22.15
Earnings Date08/04/2026
3Y+73.0%
5Y+11.0%
10Y+119.0%
3Y-20.0%
5Y+179.0%
10Y+33.0%
3Y-236.0%
5Y-186.0%
10Y-180.0%
SGRY

Surgery Partners, Inc. Cash Conversion Engine

SGRY ยท NASDAQ
Net Income98.90M
Depreciation & Amortization176.00M
Stock-Based Compensation14.80M
Change in Working Capital-110.40M
Others78.30M
Capital Expenditures-78.70M
Free Cash Flow195.60M

Cash Flow Quality Analysis

FCF Conversion Rate

197.8%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

28.7%

Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.

FCF Growth Trend

-6.7%

Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.

Working Capital Impact

-$110.40M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.

Surgery Partners, Inc. Cash Flow Statement

SGRY โ€ข NASDAQ

Surgery Partners, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
OPERATING ACTIVITIES
98.9M
12.5M
135.3M
87M
70.7M
1.3M
45.1M
-95.6M
-53M
85.1M
72.8M
-27.1M
17.7M
25.9M
176M
152.6M
118.1M
114.8M
98.8M
94.8M
76.5M
67.4M
51.9M
39.6M
34.5M
15.1M
11.7M
11.2M
16.7M
131.5M
-1.7M
21.9M
8.9M
-21.9M
8.5M
25.3M
6.9M
6.9M
-149.9M
14.1M
7.1M
5.7M
14.8M
33.3M
17.7M
18.4M
17.4M
13.2M
10.2M
9.3M
5.6M
2M
7.5M
942K
455K
411K
78.3M
89.1M
86.7M
19M
40.4M
214.8M
58M
105M
28.1M
35.1M
163.8M
38.7M
22.1M
8.4M
(0.0)
(1.6M)
(1.4M)
(1.8M)
(1.5M)
(1.7M)
(1.6M)
(2.2M)
(0.0)
(661K)
(1.1M)
(676K)
(538K)
(0.0)
-110.4M
-118.9M
-62.3M
-102.3M
-149.1M
-55.3M
-68.8M
33.2M
85M
-43.4M
-44.3M
-19.7M
-10M
-5.3M
274.3M
300.1M
293.8M
158.8M
87.1M
246.9M
129.5M
144.6M
120.9M
125.2M
84.5M
21.9M
49.1M
46.4M
INVESTING ACTIVITIES
-78.7M
-90.4M
-88.8M
-80.6M
-57.6M
-42.9M
-73.6M
-39.8M
-29.6M
-39.1M
-33.4M
-9.4M
-4.2M
-4.7M
-162.1M
-378.8M
-128.9M
-228.7M
-280.4M
-104.6M
-11.4M
-87.6M
-755.1M
-145.6M
-101.4M
-261.6M
(528K)
(1.2M)
-13.3M
-1.7M
(0.0)
(0.0)
(0.0)
(0.0)
-15.2M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
0.0
4.6M
0.0
0.0
0.0
0.0
15.2M
0.0
0.0
0.0
11.2M
0.0
0.0
0.0
7.5M
-22.2M
-7.9M
1.4M
6.3M
59.1M
-200K
-1.5M
1.3M
-145.6M
-101.4M
-1.7M
1M
1.5M
-246.6M
-488.5M
-225.6M
-307.9M
-331.7M
-88.4M
-85.2M
-128.9M
-783.4M
-184.7M
-134.8M
-271M
-3.6M
-3.5M
FINANCING ACTIVITIES
0.0
0.0
0.0
882.9M
581.8M
0.0
0.0
-2M
-2M
0.0
251M
-3.1M
0.0
0.0
158.7M
450.4M
19.5M
-644.2M
-43.8M
213.1M
-1.7M
125.1M
565.1M
171.4M
-135.7M
449.5M
123.1M
-19.5M
(0.0)
(0.0)
(0.0)
(0.0)
-5.1M
(0.0)
(0.0)
-7.8M
-1.3M
(0.0)
(0.0)
-93M
-131M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-2M
-2M
(0.0)
(0.0)
-3.1M
(0.0)
(0.0)
-216M
-188.4M
-174.7M
-196.6M
-216.6M
-146.4M
-134.2M
-121.6M
205.9M
-100.2M
-81.9M
-42.4M
-29.7M
-23.6M
-57.3M
262M
-155.2M
42.1M
316.3M
66.7M
-135.9M
-6.3M
767.7M
71.3M
33.4M
311M
-37.7M
-43.1M
CASH FLOW SUMMARY
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
662.5M
0.0
0.0
0.0
0.0
0.0
-29.6M
73.6M
-87M
-107M
71.7M
225.2M
-91.6M
9.4M
11.8M
11.8M
-17M
61.9M
7.8M
-152K
269.5M
195.9M
282.9M
389.9M
318.2M
93M
184.6M
175.2M
57.9M
57.9M
74.9M
13M
5.2M
5.4M
239.9M
269.5M
195.9M
282.9M
389.9M
318.2M
93M
184.6M
69.7M
69.7M
57.9M
74.9M
13M
5.2M
195.6M
209.7M
205M
78.2M
29.5M
204M
55.9M
104.8M
91.3M
86.1M
51M
12.5M
44.9M
41.7M

SEC Filings

SGRY - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 05, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 05, 2026
May 05, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 23, 2026
June 05, 2026
2026
10-K

10-K 2025 FY

FY

March 02, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 02, 2026
March 02, 2026
2026
8-K

8-K 2025

N/A

December 16, 2025
December 16, 2025
2025
8-K

8-K 2025

N/A

December 12, 2025
December 11, 2025
2025
8-K

8-K 2025

N/A

December 11, 2025
December 11, 2025
2025
8-K

8-K 2025

N/A

November 12, 2025
November 12, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 10, 2025
September 30, 2025
2025
Showing 1 to 10 of 196 filings